Top Markets
#1 QuantixAI QuantixAI +102.94%
#2 Pons Pons +32.45%
#3 龙虾 (Lobster) 龙虾 (Lobster) +30.82%
#4 Rain Rain +30.81%
#5 MetaDAO MetaDAO +28.44%
#6 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +21.60%
#7 Bedrock Bedrock +20.58%
#8 Prom Prom +18.28%
#9 Ontology Gas Ontology Gas +15.93%
#10 peaq peaq +15.36%
Coin of the day
QuantixAI QuantixAI
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Immunovant, Inc. Immunovant, Inc.

Immunovant, Inc.

IMVT
Kedudukan dalam Saham #2347
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase,... Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
Harga Saham
$43.38
Modal Pasaran
$8.95B
Perubahan (1 hari)
0.14%
Perubahan (1 tahun)
191.34%
Negara
US
Perdagangan Immunovant, Inc. (IMVT)

Kategori

Healthcare
Sejarah harga saham bagi Immunovant, Inc. (IMVT)
Harga penutupan tertinggi: $42.51 pada 2026-08-01

Harga penutupan terendah: $9.88 pada 2019-06-01
Sejarah harga saham Immunovant, Inc. dari 2019 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 8.62%
2025 -7.38%
2024 -34.45%
2023 163.89%
2022 99.44%
2021 -84.02%
2020 273.47%
2019 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 50.56%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 525.80%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.47 -12.71%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 8.67%
CH